HMPV is readily spread from contact with respiratory secretions from infected individuals or contaminated surfaces and objects.

There is no vaccine available for HMPV. Prevention of HMPV infection depends on good hygienic methods to reduce the spread of the virus.

Clinicians are not able to accurately diagnose HMPV infection based on signs and symptoms alone. There are many other viruses that infect the respiratory tract with a large overlap of symptoms among these infections. Diagnostic tests performed on specimens taken from the respiratory tract provide a useful aid to the diagnosis of HMPV. The direct fluorescent antibody method allows detection of the virus within two to three hours but is labor intensive and requires considerable experience. Molecular methods such as reverse transcription polymerase chain reaction-based tests are the most accurate methods to detect HMPV.

Management of an HMPV infection is generally focused on symptomatic therapy. When an HMPV infection becomes more serious and progresses to bronchiolitis, patient management goals are to relieve respiratory distress, alleviate airway obstruction and improve oxygen levels. It is important to normalize body temperature and maintain proper hydration.

https://journals.lww.com/pidj/Fulltext/2008/10001/Human_Metapneumovirus_Infection_in_Adults.9.aspx

Human Metapneumovirus (hMPV) | American Lung Association

http://wwwnc.cdc.gov/eid/article/14/1/07-0251_article.htm